Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Completed · Phase 1

Conditions studied: Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Pancreatic Cancer

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Motexafin gadolinium may increase the effectiveness of radiation therapy by making tumor cells more sensitive to treatment. PURPOSE: Phase I trial to study the effectiveness of radiation therapy plus motexafin gadolinium in treating patients with bile duct, gallbladder, or pancreatic cancer that cannot be removed surgically.

Key facts

Study ID

NCT00003411

Run by

University of Pittsburgh

Starts

1998-11-01

Expected to finish

2002-06-01

Last updated by the study team

2016-01-18

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.